Literature DB >> 25345893

Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!

Myka L Estes1, A Kimberley McAllister.   

Abstract

Neuroinflammation was once a clearly defined term denoting pathological immune processes within the central nervous system (CNS). Historically, this term was used to indicate the four hallmarks of peripheral inflammaton that occur following severe CNS injuries, such as stroke, injury or infection. Recently, however, the definition of neuroinflammation has relaxed to the point that it is often now assumed to be present when even only a single classical hallmark of inflammation is measured. As a result, a wide range of disorders, from psychiatric to degenerative diseases, are now assumed to have an integral inflammatory component. Ironically, at the same time, research has revealed unexpected nonclassical immune actions of immune mediators and cells in the CNS in the absence of pathology, increasing the likelihood that homeostatic and adaptive immune processes in the CNS will be mistaken for neuroinflammation. Thus, we suggest reserving the term neuroinflammation for contexts where multiple signs of inflammation are present to avoid erroneously classifying disorders as inflammatory when they may instead be caused by nonimmune etiologies or secondary immune processes that serve adaptive roles.
© 2014 International Society of Neuropathology.

Entities:  

Keywords:  Alzheimer's disease; T cells; autism; cytokines; microglia; schizophrenia

Mesh:

Substances:

Year:  2014        PMID: 25345893      PMCID: PMC4365495          DOI: 10.1111/bpa.12198

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  110 in total

1.  Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

Authors:  K E Balashov; D R Smith; S J Khoury; D A Hafler; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events.

Authors:  M Maes; A H Lin; L Delmeire; A Van Gastel; G Kenis; R De Jongh; E Bosmans
Journal:  Biol Psychiatry       Date:  1999-04-01       Impact factor: 13.382

3.  Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.

Authors:  Antón Alvarez; Ramón Cacabelos; Carolina Sanpedro; Manuel García-Fantini; Manuel Aleixandre
Journal:  Neurobiol Aging       Date:  2006-03-29       Impact factor: 4.673

4.  Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac Pessah; Judy Van de Water
Journal:  Brain Behav Immun       Date:  2010-08-10       Impact factor: 7.217

5.  Interleukin-6 expression in human multiple sclerosis lesions.

Authors:  L M Schönrock; G Gawlowski; W Brück
Journal:  Neurosci Lett       Date:  2000-11-10       Impact factor: 3.046

6.  Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.

Authors:  Christopher N Parkhurst; Guang Yang; Ipe Ninan; Jeffrey N Savas; John R Yates; Juan J Lafaille; Barbara L Hempstead; Dan R Littman; Wen-Biao Gan
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

7.  Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration.

Authors:  Solomon S Shaftel; Thaddeus J Carlson; John A Olschowka; Stephanos Kyrkanides; Sarah B Matousek; M Kerry O'Banion
Journal:  J Neurosci       Date:  2007-08-29       Impact factor: 6.167

8.  Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.

Authors:  P Rieckmann; M Albrecht; B Kitze; T Weber; H Tumani; A Broocks; W Lüer; A Helwig; S Poser
Journal:  Ann Neurol       Date:  1995-01       Impact factor: 10.422

9.  Zebrafish orthologue of mental retardation protein IL1RAPL1 regulates presynaptic differentiation.

Authors:  Tomoyuki Yoshida; Masayoshi Mishina
Journal:  Mol Cell Neurosci       Date:  2008-07-01       Impact factor: 4.314

10.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more
  30 in total

1.  ESE1 is Associated with Neuronal Apoptosis in Lipopolysaccharide Induced Neuroinflammation.

Authors:  Yi Feng; Huaqing Xue; Jie Zhu; Likun Yang; Feng Zhang; Rong Qian; Wei Lin; Yuhai Wang
Journal:  Neurochem Res       Date:  2016-06-27       Impact factor: 3.996

Review 2.  Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review.

Authors:  Eric A Woodcock; Ansel T Hillmer; Graeme F Mason; Kelly P Cosgrove
Journal:  Mol Neuropsychiatry       Date:  2019-05-09

3.  Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer's Disease.

Authors:  Miren Ettcheto; Sonia Abad; Dmitry Petrov; Ignacio Pedrós; Oriol Busquets; Elena Sánchez-López; Gemma Casadesús; Carlos Beas-Zarate; Eva Carro; Carme Auladell; Jordi Olloquequi; Merce Pallàs; Jaume Folch; Antoni Camins
Journal:  Mol Neurobiol       Date:  2017-07-27       Impact factor: 5.590

Review 4.  Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry.

Authors:  T Notter; J M Coughlin; A Sawa; U Meyer
Journal:  Mol Psychiatry       Date:  2017-12-05       Impact factor: 15.992

Review 5.  Role of microglia in methamphetamine-induced neurotoxicity.

Authors:  Enquan Xu; Jianuo Liu; Han Liu; Xiaobei Wang; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-06-15

Review 6.  Sifting through the surfeit of neuroinflammation tracers.

Authors:  Paul Cumming; Bjorn Burgher; Omkar Patkar; Michael Breakspear; Neil Vasdev; Paul Thomas; Guo-Jun Liu; Richard Banati
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-19       Impact factor: 6.200

7.  Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models.

Authors:  Bahareh Ajami; Nikolay Samusik; Peter Wieghofer; Peggy P Ho; Andrea Crotti; Zach Bjornson; Marco Prinz; Wendy J Fantl; Garry P Nolan; Lawrence Steinman
Journal:  Nat Neurosci       Date:  2018-03-05       Impact factor: 24.884

Review 8.  Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

Authors:  S Hunter; C Brayne
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

9.  CD300f immunoreceptor is associated with major depressive disorder and decreased microglial metabolic fitness.

Authors:  Natalia Lago; Fernanda N Kaufmann; María Luciana Negro-Demontel; Daniela Alí-Ruiz; Gabriele Ghisleni; Natalia Rego; Andrea Arcas-García; Nathalia Vitureira; Karen Jansen; Luciano M Souza; Ricardo A Silva; Diogo R Lara; Bruno Pannunzio; Juan Andrés Abin-Carriquiry; Jesús Amo-Aparicio; Celia Martin-Otal; Hugo Naya; Dorian B McGavern; Joan Sayós; Rubèn López-Vales; Manuella P Kaster; Hugo Peluffo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-09       Impact factor: 11.205

Review 10.  Maternal immune activation: Implications for neuropsychiatric disorders.

Authors:  Myka L Estes; A Kimberley McAllister
Journal:  Science       Date:  2016-08-19       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.